Search

You searched for "digital"

1151 results found

Liquid gold – platelet-rich plasma glottic injections in vocal pathology

3 July 2026 | | ENTA - Laryngology / Swallowing / Voice
Platelet-rich plasma (PRP) is being used in an increasing number of ENT conditions, with particular promise in the larynx. Voice is a defining human characteristic. The ability to communicate with one another and to use the vocal folds (VFs) for...

FESSing up

7 January 2026 | | ENTA - Rhinology / Sinus
This story is dedicated to my dear friend and much-missed colleague, Heinz Stammberger, with whom some of these moments were shared (or endured). Having used a rigid endoscope in my postgrad thesis in the early 1980s to show that the...

The future of inner ear drug delivery

1 May 2017 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric, ENTA - Otology
The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...

ENT Masterclass® China 2026

17 April 2026 -18 April 2026 | ENTA - ENT
Declan Costello, Consultant ENT Surgeon As we will all remember, April 2020 was a very difficult time to organise meetings with the global pandemic taking hold. It was deeply ironic that the ENT Masterclass meeting was due to have been...

Hearing loss toolkit updated

30 May 2024
The British Hearing Instrument Manufacturers Association (BIHIMA) and the Royal College of General Practitioners (RCGP) have updated the hearing loss toolkit they developed in 2020/21.
National Deaf Children’s Society app image.

Listening to families - the essential app for families of Deaf children

2 May 2025 | | ENTA - Audiology - Paediatric
The National Deaf Children’s Society (NDCS) has recently launched an app designed to support families with children affected by hearing loss throughout their childhood. This app was developed in response to the community’s demand for expert-guided information presented in a...

Prednisolone and/or acyclovir for Bell’s palsy

5 January 2022 | | ENTA - Head & Neck
Landmark Paper: Sullivan FM, Swan IRC, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s Palsy. N Engl J Med 2007;357(16):1598-607. Facial nerve paralysis as a consequence of Bell’s palsy can result in devastating long-term effects on...

Patient experience of necrotising otitis externa

2 March 2022 | | ENTA - Otology
Necrotising otitis externa is increasing in incidence in the UK and becoming a rising burden to patients and health services. Despite a growing body of literature on this condition, we know very little about patient experience of necrotising otitis externa....

From patient to performer

4 September 2023 | | ENTA - Laryngology / Swallowing / Voice
Peter Cawrey lives in Harpenden, Hertfordshire, with his wife Dorothy. He had a salvage laryngectomy for squamous cell carcinoma in 2015, three years following his initial radiotherapy. Due to complications and a complex recovery, he has elected not to have...

Pursuing part-time postgraduate qualifications

6 January 2023 | | ENTA - Audiology - Paediatric
Thinking of going back to university to do further study? We hear from one audiologist who identified an area of further study and specialisation and took the leap. My career in audiology began in 2003 through a traditional route in...

Help shape the future of mild to moderate hearing loss research

1 March 2015 | | ENTA - Audiology - Adult
A James Lind Alliance Priority Setting Partnership has been formed to help shape the future of research into mild-moderate hearing loss. Who is the Priority Setting Partnership? The Partnership brings together Hearing Link, Action on Hearing Loss, the British Society...

Hearing loss and Alport syndrome

1 May 2015 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric, ENTA - Genetics, ENTA - Otology
Alport syndrome (AS) includes a group of hereditary diseases caused by mutations in the COL4A3, COL4A4 or COL4A5 genes. These genes are responsible for the biosynthesis of α3, α4 and α5 collagen IV chains, which are located in the glomerular...